Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)

From: Ohio Department of Higher Education(Higher Education)
PAR-23-207

Basic Details

started - 14 Jun, 2023 (10 months ago)

Start Date

14 Jun, 2023 (10 months ago)
due - 07 Sep, 2026 (in about 2 years)

Due Date

07 Sep, 2026 (in about 2 years)
Bid Notification

Type

Bid Notification
PAR-23-207

Identifier

PAR-23-207
Department of Health and Human Services National Institutes of Health

Customer / Agency

Department of Health and Human Services National Institutes of Health
unlockUnlock the best of InstantMarkets.

Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.

Don't have an account yet? Create a free account now.

Document Type:Grants NoticeFunding Opportunity Number:PAR-23-207Funding Opportunity Title:Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)Opportunity Category:DiscretionaryOpportunity Category Explanation: Funding Instrument Type:GrantCategory of Funding Activity:HealthCategory Explanation: Expected Number of Awards: CFDA Number(s):93.242 -- Mental Health Research Grants 93.866 -- Aging ResearchCost Sharing or Matching Requirement:No Version:Synopsis 1Posted Date:Jun 14, 2023Last Updated Date:Jun 14, 2023Original Closing Date for Applications:Sep 07, 2026 Current Closing Date for Applications:Sep 07, 2026 Archive Date:Oct 13, 2026Estimated Total Program Funding: Award Ceiling: Award Floor: Document Type:Grants NoticeFunding Opportunity Number:PAR-23-207Funding Opportunity Title:Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)Opportunity
Category:DiscretionaryOpportunity Category Explanation: Funding Instrument Type:GrantCategory of Funding Activity:HealthCategory Explanation: Expected Number of Awards: CFDA Number(s):93.242 -- Mental Health Research Grants 93.866 -- Aging ResearchCost Sharing or Matching Requirement:No Version:Synopsis 1Posted Date:Jun 14, 2023Last Updated Date:Jun 14, 2023Original Closing Date for Applications:Sep 07, 2026 Current Closing Date for Applications:Sep 07, 2026 Archive Date:Oct 13, 2026Estimated Total Program Funding: Award Ceiling: Award Floor: Eligible Applicants:Private institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Special district governments Public and State controlled institutions of higher education County governments City or township governments Independent school districts Native American tribal governments (Federally recognized) Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governmentsAdditional Information on Eligibility:Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. Agency Name:National Institutes of HealthDescription:The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS. Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the development of NPS in AD and/or ADRDLink to Additional Information:https://grants.nih.gov/grants/guide/pa-files/PAR-23-207.htmlGrantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: NIH Grants Information grantsinfo@nih.govSee Section VII. Agency Contacts within the full opportunity announcement for all other inquires.

25 South Front Street Columbus OH 43215 United StatesLocation

Address: 25 South Front Street Columbus OH 43215 United States

Country : United StatesState : Ohio

You may also like

HIV Prevention and Alcohol (R01 Clinical Trials Optional)

Due: 07 May, 2026 (in about 2 years)Agency: Department of Health and Human Services National Institutes of Health

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Due: 07 Jan, 2027 (in about 2 years)Agency: Department of Health and Human Services National Institutes of Health

Please Sign In to see more like these.

Don't have an account yet? Create a free account now.

Classification

Discretionary